Table 3.

Overview of cases with non-viral hepatitis mixed cryoglobulinemia (and kidney involvement) on rituximab

Ref.	n	Age (yr)/gender	Treatment prior to RTX	Features	Response to RTX	Side-effects after RTX
Arzoo et al[28]	1	71/F	CS	C, N, R	Remission	None
Ghijsels et al[29]	1	44/M	CS, CPH, CHL	C, Ca, R	Remission	None
Koukoulaki et al[30]	1	48/F	CS, CPH	GI, P, R	Partial remission	None
Bryce et al[31]	1	NA	NA	R	No response	None
Ruch et al[32]	1	64/M	CS	R	Remission	Cold agglutinine disease, sepsis
Annear et al[33]	1	42/F	CS	C, R	Remission	None
Terrier et al[34]	7	73 ± 5/M (n = 4)	CS (n = 4)	C (n = 6), N (n = 2), A (n = 2), R (n = 7)	Remission (n = 3), partial remission (n = 1), NA (n = 3)	Severe infections (n = 4)
Wink et al[35]	1	72/F	CS, Aza	C, P, R	Remission	None
Choudhry et al[36]	1	61/F	CS, CPH	C, P, R	Remission	None
Kamel et al[37]	1	77/F	CS	C, A, R	Remission	None
Own case	1	51/M	CS, Aza	C, GI, N, R	Remission	Severe infection

A: Arthralgias; Aza: Azathioprine; C: Cutaneous; Ca: Cardiac; CHL: Chlorambucil; CPH: Cyclophosphamide; CS: Corticosteroids; GI: Gastrointestinal; N: Neurological; NA: Not available; P: Pulmonary; R: Renal; RTX: Rituximab.